26-000014 caredx lab solutions INC. Allo SEQ TX17 next generation sequencing (NGS) reagent kits
Ended Purchase Order Awarded
- Contract number
- 75N90026P00061
- Awardee
-
Caredx Lab Solutions Inc. UEI KHHBJ9FJR225
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $292,973
Award facts
- Opportunity
-
- NIHCCOPC26000014 Solicitation number
- Contract value 100% obligated
- $292,972.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- West Chester, PA, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institutes of Health Clinical Center awarded a $292,972.80 firm fixed-price purchase order to CareDx Lab Solutions Inc. for AlloSeq TX17 Next Generation Sequencing (NGS) reagent kits, with an ultimate completion date of September 30, 2026. The contract, which carries no set-aside designation, represents a continuation of the agency's relationship with CareDx Lab Solutions, a West Chester, Pennsylvania-based manufacturer specializing in genomics-based diagnostic solutions for transplant patients. The reagent kits support advanced molecular testing capabilities essential for transplant surveillance and rejection risk assessment across the pre- to post-transplant care continuum.
CareDx Lab Solutions has established itself as a trusted federal contractor through multiple prior awards from the NIH Clinical Center and other government agencies including the Department of Veterans Affairs, Department of the Navy, and Centers for Disease Control and Prevention. The company's expertise in next-generation sequencing technologies and FDA-approved transplant diagnostics positions it as a specialized provider within the federal healthcare marketplace. This purchase order reflects the NIH Clinical Center's ongoing investment in advanced molecular diagnostic capabilities to support its clinical and research missions related to organ transplantation and precision medicine initiatives.
Quick answers
Who was awarded contract 75N90026P00061?
75N90026P00061 was awarded to Caredx Lab Solutions Inc. by NIH Clinical Center (National Institutes of Health) on January 16, 2026.
How much is contract 75N90026P00061 worth?
The government has obligated $292,973 on 75N90026P00061.
Was contract 75N90026P00061 competed?
The extent of competition for 75N90026P00061 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award